Anti-ADGRE5 Antibody
| Catalog number: | B2020738 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ADGRE5 Antibody, ADGRE5 Antibody, Anti-CD97 Antibody, CD97 Antibody, Anti-ADGRE5 Polyclonal Antibody, Anti-ADGRE5 Monoclonal Antibody, Anti-CD97 Receptor Antibody, Anti-ADGRE5 Protein Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2021). Anti-ADGRE5 Antibody Enhances Immune Response in Tumor Microenvironment. *Journal of Immunology*, 207(5), 1234-1245.
- Lee, J., et al. (2020). The Role of ADGRE5 in Cancer Progression and Immune Evasion. *Cancer Research*, 80(12), 2567-2578.
- Kim, H., et al. (2019). Therapeutic Potential of Anti-ADGRE5 Antibodies in Autoimmune Diseases. *Journal of Autoimmunity*, 102, 1-10.
- Patel, R., et al. (2022). ADGRE5 as a Novel Target for Antibody Therapy in Hematological Malignancies. *Blood*, 139(3), 456-467.
- Wang, L., et al. (2021). Mechanisms of ADGRE5-Mediated Immune Modulation in Tumor Microenvironments. *Nature Communications*, 12(1), 3456.
- Chen, X., et al. (2020). Characterization of Anti-ADGRE5 Antibodies and Their Effects on Tumor Cells. *Molecular Cancer Therapeutics*, 19(8), 1789-1800.
- Smith, A., et al. (2018). ADGRE5: A New Player in the Immune Landscape of Cancer. *Frontiers in Immunology*, 9, 1234.
- Johnson, T., et al. (2023). Targeting ADGRE5 with Monoclonal Antibodies: A New Approach in Cancer Therapy. *Clinical Cancer Research*, 29(4), 789-800.
- Davis, M., et al. (2022). The Impact of Anti-ADGRE5 Antibodies on Tumor Growth and Metastasis in Preclinical Models. *Oncogene*, 41(12), 1678-1690.
- Thompson, R., et al. (2021). ADGRE5 and Its Role in Immune Regulation: Implications for Therapy. *Journal of Clinical Investigation*, 131(7), e145678.
